Perspectives on the effect of nodal downstaging and its implication of the role of surgery in stage IIIA (N2) non-small cell lung cancer.
作者信息
Martin Linda W, Mehran Reza J
机构信息
Department of Thoracic Cardiovascular Surgery, University of Virginia Health System, Charlottesville, VA, USA.
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
J Thorac Dis. 2017 Jul;9(7):E646-E652. doi: 10.21037/jtd.2017.06.24.
Abstract
摘要
相似文献
1
Perspectives on the effect of nodal downstaging and its implication of the role of surgery in stage IIIA (N2) non-small cell lung cancer.
J Thorac Dis. 2017 Jul;9(7):E646-E652. doi: 10.21037/jtd.2017.06.24.
2
Clinical outcomes of surgery after induction treatment in patients with pathologically proven N2-positive stage III non-small cell lung cancer.
J Thorac Dis. 2015 Sep;7(9):1616-23. doi: 10.3978/j.issn.2072-1439.2015.09.07.
3
Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
J Clin Oncol. 1997 Feb;15(2):712-22. doi: 10.1200/JCO.1997.15.2.712.
4
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Eur J Cardiothorac Surg. 2009 Sep;36(3):433-9. doi: 10.1016/j.ejcts.2009.04.013. Epub 2009 Jun 6.
5
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.
Ann Oncol. 2004 Nov;15(11):1645-53. doi: 10.1093/annonc/mdh435.
6
Is there a role for surgery in stage IIIA-N2 non-small cell lung cancer?
Zhongguo Fei Ai Za Zhi. 2008 Oct 20;11(5):615-21. doi: 10.3779/j.issn.1009-3419.2008.05.016.
7
Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Lung Cancer. 2006 Sep;53(3):323-30. doi: 10.1016/j.lungcan.2006.05.024. Epub 2006 Jul 17.
8
[Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Ai Zheng. 2009 Jul;28(7):725-9. doi: 10.5732/cjc.008.10849.
9
Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
J Thorac Oncol. 2007 Nov;2(11):1018-21. doi: 10.1097/JTO.0b013e318158d471.
10
Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2017 Jan;103(1):281-286. doi: 10.1016/j.athoracsur.2016.06.061. Epub 2016 Sep 9.
引用本文的文献
1
Anatomic lung resection after target therapy or immune checkpoint inhibitors treatment for initially unresectable advanced-staged non-small cell lung cancer: a case series.
Updates Surg. 2024 Nov 21. doi: 10.1007/s13304-024-02026-8.
2
Multimodality Treatment and Salvage Surgery for the Treatment of Lung Cancer.
Cancers (Basel). 2023 Jul 12;15(14):3586. doi: 10.3390/cancers15143586.
3
Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.
Thorac Cancer. 2020 Apr;11(4):1061-1067. doi: 10.1111/1759-7714.13366. Epub 2020 Feb 28.
本文引用的文献
1
Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2017 Jan;103(1):281-286. doi: 10.1016/j.athoracsur.2016.06.061. Epub 2016 Sep 9.
2
Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).
J Clin Oncol. 2016 May 1;34(13):1484-91. doi: 10.1200/JCO.2015.63.4543. Epub 2016 Feb 29.
3
Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2016 Apr;151(4):969-77, 979.e1-3. doi: 10.1016/j.jtcvs.2015.09.127. Epub 2015 Oct 19.
4
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet. 2015 Sep 12;386(9998):1049-56. doi: 10.1016/S0140-6736(15)60294-X. Epub 2015 Aug 11.
5
Management of clinical stage IIIA primary lung cancers in the National Cancer Database.
Ann Thorac Surg. 2014 Aug;98(2):424-32; discussion 432. doi: 10.1016/j.athoracsur.2014.04.067. Epub 2014 Jun 12.
6
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.
Radiother Oncol. 2014 Jan;110(1):3-8. doi: 10.1016/j.radonc.2013.08.011. Epub 2013 Oct 4.
7
Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Chest. 2013 May;143(5 Suppl):e314S-e340S. doi: 10.1378/chest.12-2360.
8
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.
Ann Thorac Surg. 2012 Sep;94(3):914-20. doi: 10.1016/j.athoracsur.2012.04.088. Epub 2012 Jul 21.
9
Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer.
Ann Thorac Surg. 2012 Jun;93(6):1807-12. doi: 10.1016/j.athoracsur.2012.03.018.
10
Bronchoscopy and endobronchial ultrasound for diagnosis and staging of lung cancer.
Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS11-6. doi: 10.3949/ccjm.79.s2.03.
Zotero 插件